While these studies demonstrate the potential of reinstating TCF4 early in development, they most closely mirror an embryonic reinstatement of TCF4 in humans rather than a postnatal intervention, and as a result, may present an overly optimistic model of viable treatment strategies for PTHS that does not align with the typical timeline of diagnosis. Here, TCF4 is linked to Pitt-Hopkins syndrome.